FRAMINGHAM, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE ANTIBODY SOCIETY INC, founded in 2007, is a small nonprofit in the Community Improvement sector that reported $467K in total revenue in fiscal year 2023. Revenue decreased 9% compared to the prior year. The organization ran a surplus of $146K, a strong 31% operating margin.
The Organization was established to further the broad interests of antibodyengineering and antibody therapeutics and to safeguard the public interest byincreasing discussion and activities to create the safe, thorough testing of antibody therapeutics. The society encompasses this increasingly diverse field by supporting the superstructure for the engineering of recombinant antibodies, single scaffold binders, etc. through basic and applied research by those in academics and the private sector. The Society also seeks to provide a forum and voice for thethousands of people now working on all facets of this global field.
EDUCATION/OUTREACH PROGRAM: As part of its mission, The Antibody Society aims to educate our members and the broader scientific community on topics important to antibody research and development. We...
EDUCATION/OUTREACH PROGRAM: As part of its mission, The Antibody Society aims to educate our members and the broader scientific community on topics important to antibody research and development. We act as an authoritative source of information about antibody therapeutics development, which we disseminate via our website, presentations and publications. We also organize and host webinars aimed especially at those beginning a career in biological sciences. In addition, we offer travel awards to student and post-doctoral members who wish to attend antibody-related meetings not organized by the Society.
MEETINGS PROGRAM: The Antibody Society facilitates discussion and interchange of ideas regarding issues of fundamental importance for basic research, therapeutic development and clinical testing in...
MEETINGS PROGRAM: The Antibody Society facilitates discussion and interchange of ideas regarding issues of fundamental importance for basic research, therapeutic development and clinical testing in the field. To achieve this objective, we serve as Scientific Advisors and Session Chairs for two key meetings, Antibody Engineering & Therapeutics (annual meeting of the Society), and Antibody Engineering & Therapeutics Europe. In addition, our Adaptive Immune Receptor Repertoire (AIRR) Community holds workshops designed to develop standards and recommendations for: 1) obtaining, analyzing, curating and comparing/sharing datasets; 2) using and validating tools for analyzing AIRR data; 3) relating datasets to other big data sets, such as microarray, flow cytometric data; and 4) legal and ethical issues involving the use and sharing of AIRR data sets derived from human sources. As a member of the Federation of Clinical Immunology Societies, we also organize Symposia held during their annual meeting.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $466,729 | $514,047 | -0.1% |
| Expenses | $320,742 | $364,623 | -0.1% |
| Net Income | $145,987 | $149,424 | 0.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Janice M Reichert PhD | COO | 40.00 |
Officer
Director
|
$125,397 | $22,848 | $148,245 |
| John Desjarlais | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Alex Lugovskoy | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| E Sally Ward | President & Dir | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Paul W H I Parren PhD | Board Chair | 1.00 |
Director
|
$0 | $0 | $0 |
| Kerry Chester PhD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Janine Schuurman | Vice Pres/Direc | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Mitchell Ho | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Eline Luning Prak | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Peter Thomson | Treasurer | 1.00 |
Officer
|
$0 | $0 | $0 |
| Ingrid Kingma | Clerk | 1.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $466,729 | $320,742 | $986,016 | $145,987 |
| 2022 | $514,047 | $364,623 | $840,259 | $149,424 |
| 2021 | $334,668 | $267,665 | $692,229 | $67,003 |
| 2020 | $338,977 | $204,020 | $623,602 | $134,957 |
| 2019 | $354,105 | $237,813 | $497,529 | $116,292 |
| 2019 | $354,105 | $237,813 | $497,529 | $116,292 |
| 2018 | $288,169 | $198,860 | $372,353 | $89,309 |
Compare THE ANTIBODY SOCIETY INC with other nonprofits in Massachusetts and across the country.